Drugs / RSVpreF + qIRV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05788237 | Mar → Sep 2023 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSVpreF + qIRV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05788237 ↗ |
| Modality | Vaccine | “respiratory combination vaccine candidates” NCT05788237 ↗ |